Clinical trial
Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome: a Multi-center, Three-period, Randomized Cross-over Superiority Trial (FINCROSS - Finnish Crossover Trial for Carpal Tunnel Syndrome)
NCT05637294 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome: a Multi-center, Three-period, Randomized Cross-over Superiority Trial (FINCROSS - Finnish Crossover Trial for Carpal Tunnel Syndrome)
- Lead sponsor
- Tampere University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 15, 2023
- Completion date
- December 31, 2028
- Enrollment
- 110 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.